Specifically, a type of carb in Prunella vulgaris has been shown to block the replication of HSV cells in test-tube studies ( In addition to blocking the virus from spreading, Prunella vulgaris may protect against herpes by stimulating the activity of immune cells like macrophages, which help your body fight infection ( Animal studies have found that topical creams containing Prunella vulgaris significantly reduce the number of sores and skin lesions caused by the herpes virus ( While these results are promising, human studies are needed to better understand whether treatments containing Prunella vulgaris can help treat herpes
ZDHHC3 mediates palmitoylation of PD-L1 at the C272 residue within its transmembrane domain, thereby preventing its ubiquitination and subsequent lysosomal degradation

[1] GLP-1s remain covered for: BMI 40 (Class III/morbid obesity) Type 2 Diabetes (Mounjaro, not Wegovy) Major Adverse Cardiac Events history Employers who opt-in to add weight loss drug coverage WHAT KAISER REQUIRES FIRST Kaiser Wegovy Step Therapy Requirements Even in regions where Kaiser covers Wegovy, you must typically "fail" multiple other treatments first: Kaiser Northwest Example (Most Documented) To qualify for Wegovy coverage in Kaiser Northwest, you must demonstrate: [3] Kaiser Wegovy Coverage Criteria BMI 30 (obesity) OR BMI 27 with a comorbidity (a related health condition like hypertension, diabetes, or high cholesterol) Age 18+ Following a structured diet and exercise program (documented, not just attested) Failed at least 2 prior weight loss medications [8] : Phentermine Diethylpropion Qsymia (phentermine/topiramate) Contrave (naltrexone/bupropion) Tried semaglutide (Wegovy or Ozempic) for minimum 6 months and either: It was ineffective (didn't achieve target weight loss) Cannot tolerate due to allergy, serious side effects, or contraindication Continuation Requirements (To Keep Coverage) Initial approval typically for 12 months Must document at least 5% weight loss after starting semaglutide to continue coverage Bariatric medicine chart review required before switching from semaglutide to Wegovy Kaiser's Internal "Medical Weight Management" Program Kaiser often requires patients to enroll in their internal weight management program before approving GLP-1s

Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier
Many individuals begin experiencing reduced hunger, improved portion control, and fewer cravings as their body adjusts to the treatment